Phyllis K. Bellin
Director of Finance/CFO at Galimedix Therapeutics, Inc. (Maryland)
Profile
Phyllis K.
Bellin is currently the Chief Financial Officer & Director at Galimedix Therapeutics, Inc. She previously worked as a Corporate Lending Officer at the University of Medicine & Dentistry of New Jersey and as Secretary, Treasurer & VP-Administration at Aevi Genomic Medicine, Inc. She holds an MBA degree from The Trustees of Columbia University in The City of New York.
Phyllis K. Bellin active positions
| Companies | Position | Start |
|---|---|---|
Galimedix Therapeutics, Inc. (Maryland)
 Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Director of Finance/CFO | - |
Former positions of Phyllis K. Bellin
| Companies | Position | End |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
| AEVI GENOMIC MEDICINE, INC. | Director of Finance/CFO | 2013-09-15 |
Training of Phyllis K. Bellin
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Health Services |
- Stock Market
- Insiders
- Phyllis K. Bellin